IMVT

IMVT Net Income Growth

-20.32%TTM

Period ending:

IMVT TTM Net Income YoY %%
IMVT TTM Net Income YoY %86.63%-927.00%
2020-03-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

IMVT net income growth history

Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 26 observations from Mar 31, 2020 to Jun 30, 2026.

Immunovant Inc Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income Growth
-20.3249%
-22.1743%
-21.2926%
-43.863%
-64.1184%
-59.5768%
-57.2034%
-26.541%
-11.461%
-22.9314%
-22.5215%
-44.3302%
-46.7449%
-34.6009%
-44.2807%
-38.053%
-49.857%
-45.889%
-37.9598%
-61.459%
-90.3032%
-240.6273%
-808.4315%
-828.9046%
-289.0984%
-61.1782%

Compare net income growth

Other companies in Health Care. Each page shows its own reporting periods and currency.

Compare all covered stocks by net income growth →

All IMVT financial metrics · IMVT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.